Evidence map›Paper›PMID 32469979›Full record

ArticlePloS one2020

Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake.

Erika Liktor-Busa, Kiera T Blawn, Kathryn L Kellohen, Beth M Wiese, Vani Verkhovsky, Jared Wahl, Anjali Vivek, Seph M Palomino, Thomas P Davis, Todd W Vanderah and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Erika Liktor-BusaDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Kiera T BlawnDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Kathryn L KellohenDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Beth M WieseDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Vani VerkhovskyDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Jared WahlDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Anjali VivekDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Seph M PalominoDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-8730-3271
Thomas P DavisDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Todd W VanderahDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
Tally M Largent-MilnesDepartment of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-7599-102X
University of Arizona · US

Funding

Blood Brain Barrier and Migraine: Effect on Therapy (Diversity Supplement)R01NS099292 · NINDS · UNIVERSITY OF ARIZONA · PI MILNES, TALLY MARIE · 2017 to 2021
$1.7M
Primary Afferent Transmission in the Trigeminal Dorsal HornF32DE022499 · NIDCR · OREGON HEALTH & SCIENCE UNIVERSITY · PI MILNES, TALLY MARIE · 2011 to 2014
$127k
NIDCR NIH HHS F32 DE022499NINDS NIH HHS R01 NS099292
6 · The paper itself

Abstract

Disruption of blood-brain barrier integrity and dramatic failure of brain ion homeostasis including fluctuations of pH occurs during cortical spreading depression (CSD) events associated with several neurological disorders, including migraine with aura, traumatic brain injury and stroke. NHE1 is the primary regulator of pH in the central nervous system. The goal of the current study was to investigate the role of sodium-hydrogen exchanger type 1 (NHE1) in blood brain barrier (BBB) integrity during CSD events and the contributions of this antiporter on xenobiotic uptake. Using immortalized cell lines, pharmacologic inhibition and genetic knockdown of NHE1 mitigated the paracellular uptake of radiolabeled sucrose implicating functional NHE1 in BBB maintenance. In contrast, loss of functional NHE1 in endothelial cells facilitated uptake of the anti-migraine therapeutic, sumatriptan. In female rats, cortical KCl but not aCSF selectively reduced total expression of NHE1 in cortex and PAG but increased expression in trigeminal ganglia; no changes were seen in trigeminal nucleus caudalis. Thus, in vitro observations may have a significance in vivo to increase brain sumatriptan levels. Pharmacological inhibition of NHE1 prior to cortical manipulations enhanced the efficacy of sumatriptan at early time-points but induced facial sensitivity alone. Overall, our results suggest that dysregulation of NHE1 contributes to breaches in BBB integrity, drug penetrance, and the behavioral sensitivity to the antimigraine agent, sumatriptan.

Indexed as

AnimalsBlood-Brain BarrierBrainCentral Nervous SystemCortical Spreading DepressionDisease Models, AnimalEndothelial CellsFemaleGene Expression RegulationHumansInjections, IntraperitonealMigraine with AuraRatsSodium-Hydrogen Exchanger 1SumatriptanTrigeminal GanglionSLC9A1 protein, humanSodium-Hydrogen Exchanger 1Sumatriptan

Identifiers

PMID32469979
PMCPMC7259629
OpenAlexW3032411770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.